Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Obstetrics & Gynecology|December 29, 2025
Eradicating cervical cancer in the poorest regions of the worldCourtney Fant, Krishnansu Tewari
Current Opinion in Obstetrics & Gynecology|January 3, 2023
The current status of immunotherapy in the treatment of primary advanced and recurrent endometrial cancerVirginia E Fontenot, Krishnansu Tewari
World Journal of Clinical Oncology|April 14, 2015
Sentinel lymph node mapping of a breast cancer of the vulva: Case report and literature reviewJames Cripe, Ramez Eskander, Krishnansu Tewari
Gynecologic Oncology|March 26, 2025
Clinical applications of antibody drug conjugates for gynecologic malignancies: Review of available medicines and emerging therapeuticsAlyssa C Bujnak, Samantha A Solaru, Krishnansu Tewari
American Journal of Obstetrics and Gynecology|July 1, 2008
Cervical neoplasia in pregnancy. Part 2: current treatment of invasive diseaseMark I Hunter, Krishnansu Tewari, Bradley J Monk
Gynecologic Oncology Reports|May 24, 2021
Lung cancer diagnosed on pap smear: A case report and review of the literatureMarie-Claire Leaf, Diana Pearre, Fabio Cappuccini, et al.
Gynecologic Oncology|August 14, 2012
Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancerKimberly K Leslie, Michael W Sill, Heather A Lankes, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Implementation Science : IS|May 12, 2025
A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare systemChun R Chao, Nancy Cannizzaro, Erin E Hahn, et al.
Gynecologic Oncology|August 16, 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experienceKate E Oliver, William E Brady, Michael Birrer, et al.
Pageof 2